Explore more publications!

Technology Journal of Ohio: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal of Ohio.

Press releases published on September 8, 2025

New Custom Reports from Locate Strategy Now Available for All Industries
Manuka Launches New AI, Design, and Marketing Services to Help Law Firms Grow Smarter, Faster, and Stronger
Ocusell Announces First Multi-MLS Initiative With Addition Of Three MLSs In New Jersey, New York
MLS Now Announces Bold New Brand Identity: Powering Progress for Agents in Tomorrow’s Market
Voxtur Announces Cease Trade Order and Notice of Default
Insider Perks Launches 'The Outdoor Hospitality Innovator' Blog to Address Critical Industry Knowledge Gap
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry
Diginex Announces Completion of Eight to One Stock Split Paid as Bonus Shares
Kleen HY-DRO-GEN INC. Announces Commencement of Trading
Integrity Jobs Empowers Ohio Job Seekers With Affordable, Human-First Recruiting Services
Computer Resources of America Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors 
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
House of Doge Treasury Partner CleanCore Solutions Acquires 285,420,000 DOGE with Strategic Goal to Accumulate First Milestone Target of 1 Billion DOGE in 30 Days as the Newly Launched Official Dogecoin Treasury
PharmAla Completes Import of LaNeo MDMA for US Distribution
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
CompoSecure to Move Stock Exchange Listing to NYSE
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions